Top Markets
#1 DogBull DogBull +105.02%
#2 Siacoin Siacoin +53.17%
#3 ADO Protocol ADO Protocol +46.57%
#4 UnifAI Network UnifAI Network +44.82%
#5 MarsCoin MarsCoin +42.26%
#6 Useless Coin Useless Coin +23.51%
#7 Magma Finance Magma Finance +22.41%
#8 Ontology Gas Ontology Gas +20.59%
#9 Cash Cat Cash Cat +15.71%
#10 Apertum Apertum +14.51%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Opus Genetics, Inc. Opus Genetics, Inc.

Opus Genetics, Inc.

IRD
Classement en actions #16217
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Prix de l'action
$3.70
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$305.87M
Changement (1 jour)
-3.53%
Changement (1 an)
203.66%
Pays
US
Échange Opus Genetics, Inc. (IRD)

Catégorie

Healthcare
Historique du prix de l'action pour Opus Genetics, Inc. (IRD)
Prix de clôture le plus élevé : $3.59 le 2026-07-01

Prix de clôture le plus bas : $1.30 le 2024-09-01
Historique du prix de l'action de Opus Genetics, Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 51.09%
2025 96.16%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 40.18%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.14%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 538.73%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.37 -11.93%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 4.92%
CH